Izhak Haviv

AID Genomics Group Ltd. is a research and development driven Israeli company that focuses on precision medicine-based diagnostics for oncology, hereditary rare diseases, and infectious diseases. AID Genomics Group is based in Rehovot, IL and was founded in 2018 by King Shiu Wu, Snir Zano, and Izhak Haviv. The company's advanced testing platforms were developed by a team of experts in oncology, molecular biology, molecular pathology, genomics, and bioinformatics. Snir Zano has been the CEO since 2018.

AID Genomics Group Ltd. is a research and development driven Israeli company that focuses on precision medicine-based diagnostics for oncology, hereditary rare diseases, and infectious diseases. AID Genomics Group is based in Rehovot, IL and was founded in 2018 by King Shiu Wu, Snir Zano, and Izhak Haviv. The company's advanced testing platforms were developed by a team of experts in oncology, molecular biology, molecular pathology, genomics, and bioinformatics. Snir Zano has been the CEO since 2018.

AID Genomics Group Ltd. is a research and development driven Israeli company that focuses on precision medicine-based diagnostics for oncology, hereditary rare diseases, and infectious diseases. AID Genomics Group is based in Rehovot, IL and was founded in 2018 by King Shiu Wu, Snir Zano, and Izhak Haviv. The company's advanced testing platforms were developed by a team of experts in oncology, molecular biology, molecular pathology, genomics, and bioinformatics. Snir Zano has been the CEO since 2018.